Literature DB >> 29256334

Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.

Troy A Webber1, Jason R Soble1,2.   

Abstract

OBJECTIVE: Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) Reliable Digit Span (RDS), RDS-revised (RDS-R), and age-corrected scaled score (ACSS) are validated and commonly used embedded performance validity tests (PVTs), though existing validation studies have largely examined younger (approximate ages 19-35) patients with mild traumatic brain injury or those without cognitive impairment. This study compared the classification accuracy of RDS, RDS-R, and ACSS in a mixed clinical sample of relatively older (M age = 54.61) veterans with and without neurocognitive impairment.
METHOD: During a comprehensive neuropsychological evaluation, 113 clinically-referred veterans completed the WAIS-IV Digit Span subtest and the following criterion PVTs: Dot Counting Test, Word Choice Test, and Test of Memory Malingering. Those with ≤1 criterion PVT failure were classified as valid (n = 87), whereas those with ≥2 failures were classified as noncredible (n = 26). Among valid participants, 49% were cognitively impaired.
RESULTS: RDS, RDS-R, and ACSS all significantly predicted validity group membership with respective areas under the curve (AUCs) of .79, .81, and .85, and optimal cut scores of RDS ≤ 5, RDS-R ≤ 9, and ACSS ≤ 5. Lower accuracy and AUCs were observed for the valid-cognitively impaired subsample across indices, but to a greater degree for traditional RDS. ACSS evidenced maximal sensitivity/specificity for the total sample (≤5; .62/.87), cognitively unimpaired subsample (≤5; .62/.95), and cognitively impaired subsample (≤4; .39/.86).
CONCLUSIONS: ACSS yielded better classification accuracy and sensitivity/specificity than RDS and RDS-R. While all three indices have utility as embedded PVTs, ACSS ≤ 5 may be most robust to cognitive impairment while identifying noncredible performance.

Entities:  

Keywords:  Assessment; elderly/geriatrics/aging; malingering/symptom validity testing

Mesh:

Year:  2017        PMID: 29256334     DOI: 10.1080/13854046.2017.1415374

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  7 in total

Review 1.  A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the Advanced Clinical Solutions Word Choice Test as a Performance Validity Test.

Authors:  Matthew T Bernstein; Zachary J Resch; Gabriel P Ovsiew; Jason R Soble
Journal:  Neuropsychol Rev       Date:  2021-01-15       Impact factor: 7.444

Review 2.  Victoria Symptom Validity Test: A Systematic Review and Cross-Validation Study.

Authors:  Zachary J Resch; Troy A Webber; Matthew T Bernstein; Tasha Rhoads; Gabriel P Ovsiew; Jason R Soble
Journal:  Neuropsychol Rev       Date:  2021-01-12       Impact factor: 7.444

3.  Eye Movement Desensitization (EMD) to reduce posttraumatic stress disorder-related stress reactivity in Indonesia PTSD patients: a study protocol for a randomized controlled trial.

Authors:  Eka Susanty; Marit Sijbrandij; Wilis Srisayekti; Anja C Huizink
Journal:  Trials       Date:  2021-03-04       Impact factor: 2.279

4.  Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?

Authors:  Philippe Voruz; Alexandre Cionca; Isabele Jacot de Alcântara; Anthony Nuber-Champier; Gilles Allali; Lamyae Benzakour; Marine Thomasson; Patrice H Lalive; Karl-Olof Lövblad; Olivia Braillard; Mayssam Nehme; Matteo Coen; Jacques Serratrice; Jérôme Pugin; Idris Guessous; Basile N Landis; Dan Adler; Alessandra Griffa; Dimitri Van De Ville; Frédéric Assal; Julie A Péron
Journal:  Brain Commun       Date:  2022-03-09

Review 5.  Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.

Authors:  Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson
Journal:  Curr Psychiatry Rep       Date:  2021-07-13       Impact factor: 8.081

6.  Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site, randomized controlled trial.

Authors:  Stephen Benjamin Peckham; Emily Ionson; Marouane Nassim; Kevin Ojha; Lena Palaniyappan; Joe Gati; Jean Thebérge; Andrea Lazosky; Mark Speechley; Imants Barušs; Soham Rej; Akshya Vasudev
Journal:  Trials       Date:  2019-10-24       Impact factor: 2.279

Review 7.  Future Directions in Performance Validity Assessment to Optimize Detection of Invalid Neuropsychological Test Performance: Special Issue Introduction.

Authors:  Jason R Soble
Journal:  Psychol Inj Law       Date:  2021-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.